Eyenovia Q3 net loss $7.3M; acquired US rights to APP13007; appointed new director

HYPERION DEFI, INC.

2023-Q3 EPS reported -$0.50 revenue$1,198

Net loss of ~$7.3M ($0.18 EPS) in Q3 2023, vs ~$7.3M loss ($0.21 EPS) in Q3 2022.
Cash & equivalents $20.7M at Sept 30, 2023, down from $22.9M at Dec 31, 2022.
Acquired US commercial rights to APP13007 (post-surgical ocular pain/inflammation); PDUFA date March 4, 2024.
FDA approved Coastline International as Mydcombi contract manufacturer; national launch planned early 2024.
Michael Geltzeiler appointed as independent director and Audit Committee chair, effective Nov 14, 2023.

item 2.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael Geltzeiler

Director and Chair of Audit Committee

HYPD · HYPERION DEFI, INC.

Effective: 2023-11-14
Filed: November 13, 2023, 6:59 PM ET

On November 10, 2023, the Board of Directors (the “Board”) of the Company appointed Michael Geltzeiler to serve on the Board and as the Chair of the Audit Committee of the Board (the “Audit Committee”), in each case, effective November 14, 2023.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HYPERION DEFI, INC. reported the third quarter ended September 30, 2023 results: net income approximately $(7.3) million, EPS $(0.18) per share.

Period: the third quarter ended September 30, 2023
Net income: approximately $(7.3) million
EPS: $(0.18) per share
Result: reported results

Exact text from the filing

For the third quarter of 2023, net loss was approximately $(7.3) million, or $(0.18) per share compared to a net loss of approximately $(7.3) million, or $(0.21) per share, for the third quarter of 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Geltzeiler was appointed as Director and Chair of Audit Committee at HYPERION DEFI, INC..

Action: appointed
Role: Director and Chair of Audit Committee

Exact text from the filing

On November 10, 2023, the Board of Directors (the “Board”) of the Company appointed Michael Geltzeiler to serve on the Board and as the Chair of the Audit Committee of the Board (the “Audit Committee”), in each case, effective November 14, 2023.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

HYPERION DEFI, INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-117228

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.